RECANATI LEON

SEC Form 4 insider
Evogene Ltd. ($EVGN)
1 thesis · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d
3d
1w
1m
3m
6m
1y

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$EVGNSEC Form 4bullish
RECANATI LEON · Evogene Ltd. · 4h agono track record yet
Long 460,000 shares of EVGN
Bought 460,000 @ $0.64 avg · $292,100 · 2026-08-11

Form 4: RECANATI LEON bought EVGN

RECANATI LEON (Director at Evogene Ltd.) reported an open-market purchase of 460,000 shares of EVGN at an average $0.64, roughly $292,100, in a Form 4 filed 2026-08-13.

Now $0.631m ago
1d
3d
1w
1m
3m
6m
1y
View filing on SEC.gov →

End of results.